MedTrace Logo

Clinical and Biological Characteristics of Psychotic Depression

NCT00576095 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 73

Last updated 2014-03-14

No results posted yet for this study

Summary

The primary objective of this study is to investigate the relationships among findings in structural and functional neuroimaging, cognitive testing and HPA (hypothalamic-pituitary-adrenal) axis dysregulation in psychotic depression.

Conditions

  • Depression
  • Psychotic Disorders
  • Depressive Disorder, Major

Sponsors & Collaborators

Principal Investigators

  • Alan Schatzberg · Stanford University

  • Jennifer Keller · Stanford University

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2005-08-31
Primary Completion
2012-06-30
Completion
2012-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00576095 on ClinicalTrials.gov